Patents by Inventor William E. Frietze

William E. Frietze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6348504
    Abstract: This invention relates generally to oxime ethers which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: February 19, 2002
    Inventors: Richard E. Olson, William E. Frietze
  • Patent number: 6218391
    Abstract: Corticotropin releasing factor (CRF) antagonists of Formula (I) and their use in treating psychiatric disorders and neurological diseases including major depression, anxiety-related disorders, post-traumatic stress disorders, supranuclear palsy and eating disorders.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: April 17, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Argyrios Georgios Arvanitis, Richard E. Olson, Charles R. Arnold, III, William E. Frietze
  • Patent number: 6159980
    Abstract: Corticotropin releasing factor (CRF) antagonists of Formula (I) ##STR1## and their use in treating psychiatric disorders and neurological diseases including major depression, anxiety-related disorders, post-traumatic stress disorders, supranuclear palsy and eating disorders.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: December 12, 2000
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Argyrios Georgios Arvanitis, Richard E. Olson, Charles R. Arnold, III, William E. Frietze